Beijing Somur Technology Co., Ltd. (known as Somur Genetics), which was founded in 2015, is the leader of consumer genomics industry in China.Somur is combining D2C (direct to customer) genetic testing with cutting-edge technologies, i.e. big data mining and artificial intelligence, as well as the concept of modern precision medicine. Somur is committed to providing both individual and enterprise customers with personal health assessment and precision health management with personal genomic data as the core, and accurately reveal the great value of individual life data. At present, maintaining more than 50,000 human DNA samples and strong product development ability, Somur becomes not only the company with the largest cumulative sample size, but also far ahead of similar enterprises, in terms of product completion and iterative speed. Somur established strategic partnerships with many well-known companies and institutions. Somur’s "Smart precision health management SaaS" was recommended by the China Science and Technology Association as the national key project at 2016 National Mass Innovation and Entrepreneurship Week, and presented to the Prime Minister.